Tags - tag

FDA approves gene therapy with $2.1M price tag

TEHRAN, May 25 -The Food and Drug Administration on Friday approved a $2.125 million treatment for spinal muscular atrophy, a genetic illness known as muscle-wasting disease that kills many babies before they turn 2.

News ID: 39841 Publish Date : 2019/05/25

Young journalists club

FDA approves gene therapy with $2.1M price tag

China’s EXIM inks $1.5bn deal for high-speed rail in Iran (1 Comment)